Table 2.
Correlation between piR-017724 and clinical characteristics.
| Clinical characteristic | piR-017724 expression | P-value | |
|---|---|---|---|
| Low (n=22) | High (n=22) | ||
| Sex | 1.000 | ||
| Male | 17 (77.27%) | 18 (81.82%) | |
| Female | 5 (22.73%) | 4 (18.18%) | |
| Age | 0.069 | ||
| ≥60 | 7 (31.82%) | 13 (59.09%) | |
| <60 | 15 (68.18%) | 9 (40.91%) | |
| Tumor size, cm | 3.64 ± 2.02 | 4.92 ± 2.23 | 0.052 |
| Tumor stage | 0.042 | ||
| I-II | 3 (13.64%) | 9 (40.91%) | |
| III-IV | 19 (86.36%) | 13 (59.09%) | |
| Vascular invasion | 0.642 | ||
| Yes | 5 (22.73%) | 8 (36.36%) | |
| No | 4 (18.18%) | 3 (13.64%) | |
| Missing | 13 (59.09%) | 11 (50.00%) | |
| AFP, ng/mL | 147.40 [3.23, 1046.32] | 190.32 [3.94, 2234.50] | 0.778 |
| ALT, U/L | 33.00 [17.00, 52.50] | 27.00 [20.00, 46.50] | 0.900 |
| AST, U/L | 31.00 [26.00, 51.50] | 31.00 [26.50, 44.00] | 0.867 |
P-value ≤ 0.05 indicate statistical significance.